Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@Tickeron 8
@dhovekamp42 4
@tradersreport 3
@OlympiaReport 3
@ThisLincolnian 2

Recent Tweets for FATE

TickerReport @TickerReport
Fate Therapeutics $FATE Stock Rating Lowered by ValuEngine https://t.co/XEv1NDatey
October 11th 2019, 9:10pm
gcassidy718 @gcassidy718
$FATE here we go!! 3.57 % change recently https://t.co/rJRHk0DOAl
October 11th 2019, 6:10pm
Sqwii @Sqwii
$FATE looking good here for a small 10-20% bounce here imo #bounce https://t.co/G43VX79BgV
October 11th 2019, 10:10am
osok762 @osok762
Out $LABU 5 pts out $FATE 3 pts. Taking the base hits
October 11th 2019, 9:10am
tradersreport @tradersreport
RT @Tickeron: $FATE's Aroon indicator reaches into Uptrend on October 9, 2019. View odds for this and other indicators: https://t.co/IOLou7…
October 10th 2019, 9:10pm
Tickeron @Tickeron
$FATE's Aroon indicator reaches into Uptrend on October 9, 2019. View odds for this and other indicators:… https://t.co/tFZw5NStry
October 10th 2019, 9:10pm
TradeFlags @TradeFlags
#DeathCross $FATE at 14.00 R11 HiLo 25% T1Y 26 strong_buy 1.4 fwdPE -8.9 DIV N/A #Fate Thera #stocks #trading… https://t.co/P8WWqIOUWH
October 10th 2019, 8:10pm
osok762 @osok762
$LABU up 5 pts in play 2morrow. $FATE 14
October 10th 2019, 5:10pm
BlueBioNow @BlueBioNow
$FATE I am gona keep buying until it hits $15.95 dollars -2.82 % change https://t.co/BXYgVAHbXB
October 9th 2019, 10:10pm
registrarjourn @registrarjourn
Fate Therapeutics $FATE Trading Down 8.7% https://t.co/jrrtzWqzbl
October 9th 2019, 8:10pm
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Trading Down 8.7% https://t.co/01S7Ja99e7
October 9th 2019, 8:10pm
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Trading Down 8.7% https://t.co/3P4iWq8Ddd
October 9th 2019, 8:10pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Shares Down 8.7% https://t.co/0vmpw7nM9e
October 9th 2019, 8:10pm
Tickeron @Tickeron
$FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators:… https://t.co/lQP4nMUh1y
October 9th 2019, 8:10pm
RiddaKilla76 @RiddaKilla76
@mchilberg Now it looks like $FATE s turn at a spanking. I feel like hedge funds are just taking turns day by day w… https://t.co/ilGlgDMKG8
October 9th 2019, 2:10pm
1MinuteStock @1MinuteStock
Wondering about risks of $FATE? The 63-day volatility is 29.37% https://t.co/qWY2XKvF0U
October 9th 2019, 2:10pm
tradersreport @tradersreport
RT @Tickeron: $FATE in Uptrend: price expected to rise as it breaks its lower Bollinger Band on October 1, 2019. View odds for this and oth…
October 8th 2019, 7:10pm
Tickeron @Tickeron
$FATE in Uptrend: price expected to rise as it breaks its lower Bollinger Band on October 1, 2019. View odds for th… https://t.co/0bvjo5CUE7
October 8th 2019, 7:10pm
dakotafinancial @dakotafinancial
Fate Therapeutics $FATE Downgraded to Buy at ValuEngine https://t.co/t3136APGLz
October 8th 2019, 11:10am
dhovekamp42 @dhovekamp42
@OnlyBios @FINVIZ_com Maybe you mix things and think of $AFMD as the future competitor or partner of $FATE? (and s… https://t.co/H5UaCxN7CH
October 8th 2019, 10:10am
dhovekamp42 @dhovekamp42
$FATE chart pattern complete https://t.co/hKZ6KqwNWn via @FINVIZ_com
October 8th 2019, 9:10am
bbnsnews @bbnsnews
Fate Therapeutics $FATE Downgraded by ValuEngine https://t.co/HKZ0o6s9nx
October 8th 2019, 12:10am
Tickeron @Tickeron
$FATE in Uptrend: price expected to rise as it breaks its lower Bollinger Band on October 1, 2019. View odds for th… https://t.co/kusc2sDzNA
October 7th 2019, 6:10pm
56913a174ad0444 @56913a174ad0444
RT @Quantumup1: $FATE initiated with a Buy, $27 PT at Stifel. https://t.co/0H9KYry0zx
October 6th 2019, 5:10pm
stockmaster2001 @stockmaster2001
RT @semodough: $FATE Fate Is Early Stage, But Has A Number Of NK Assets Behind FT500 and FT516 https://t.co/USGblluUq3
October 5th 2019, 7:10pm
semodough @semodough
$FATE Fate Is Early Stage, But Has A Number Of NK Assets Behind FT500 and FT516 https://t.co/USGblluUq3
October 5th 2019, 7:10pm
ThisLincolnian @ThisLincolnian
Fate Therapeutics $FATE Coverage Initiated at Stifel Nicolaus https://t.co/4D6MRx6Tk4
October 5th 2019, 2:10am
WeekHerald @WeekHerald
Fate Therapeutics $FATE Coverage Initiated at Stifel Nicolaus https://t.co/BhyXevhPEf
October 5th 2019, 2:10am
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Coverage Initiated at Stifel Nicolaus https://t.co/ClSPPWFDo4
October 5th 2019, 2:10am
dhovekamp42 @dhovekamp42
RT @Tickeron: $FATE in Downtrend: Stochastic indicator sits in oversold zone for 9 days. View odds for this and other indicators: https://t…
October 4th 2019, 9:10pm
Tickeron @Tickeron
$FATE in Downtrend: Stochastic indicator sits in oversold zone for 9 days. View odds for this and other indicators:… https://t.co/VqNOs09Tgk
October 4th 2019, 8:10pm
CentralChartsEN @CentralChartsEN
$FATE #FATETHERAPEUTICS - Daily: FATE THERAPEUTICS INC. is part of a very strong bearish trend. Traders may conside… https://t.co/xPacfvRQVJ
October 4th 2019, 3:10am
Londinia_IA @Londinia_IA
$FATE #FATETHERAPEUTICS - Daily: FATE THERAPEUTICS INC. is part of a very strong bearish trend. Traders may conside… https://t.co/DXQeRWxgQI
October 4th 2019, 3:10am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Shares Down 6.4% https://t.co/QE0jogUorj
October 4th 2019, 2:10am
tradersreport @tradersreport
RT @Tickeron: $FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators: https://t.co/quDY…
October 3rd 2019, 7:10pm
Tickeron @Tickeron
$FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators:… https://t.co/6fIPVxqhN4
October 3rd 2019, 7:10pm
larrywabrams @larrywabrams
$FATE Chief Scientific Officer Dan Shoemaker presenting 10-3-19 after hours Wednesday at ARM in Carlsbad, CA. Stoc… https://t.co/cMiFFAYncq
October 3rd 2019, 6:10pm
Tickeron @Tickeron
$FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators:… https://t.co/WP9RIU4vYv
October 2nd 2019, 7:10pm
ThisLincolnian @ThisLincolnian
Fate Therapeutics $FATE Shares Down 6.4% https://t.co/ZIvRFGCmC9
October 1st 2019, 11:10pm
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Shares Down 6.4% https://t.co/g7XnsVyowB
October 1st 2019, 11:10pm
WeekHerald @WeekHerald
Fate Therapeutics $FATE Shares Down 6.4% https://t.co/Y7pFrg0yDH
October 1st 2019, 10:10pm
ProTradersNews @ProTradersNews
$FATE: Stifel Bullish On Iovance And Fate Therapeutics, Neutral On …: https://t.co/JbxfJOCzBw
October 1st 2019, 2:10pm
Tickeron @Tickeron
$FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators:… https://t.co/KS11nQ51oB
September 30th 2019, 10:09pm
IRAMarketReport @IRAMarketReport
Fate Therapeutics $FATE Research Coverage Started at Stifel Nicolaus https://t.co/SPTjW7dR5J #markets
September 30th 2019, 6:09pm
chaffeybreeze @chaffeybreeze
Fate Therapeutics $FATE Research Coverage Started at Stifel Nicolaus https://t.co/rN2VzjgxRs #stocks
September 30th 2019, 6:09pm
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Research Coverage Started at Stifel Nicolaus https://t.co/jxWGtlRBgG
September 30th 2019, 6:09pm
Quantumup1 @Quantumup1
$FATE initiated with a Buy, $27 PT at Stifel. https://t.co/0H9KYry0zx
September 30th 2019, 4:09pm
GNWLive @GNWLive
Fate Therapeutics Announces the Opening of its cGMP Manufacturing Facility Dedicated to iPSC-derived Cell $FATE https://t.co/6PI9suzXRM
September 30th 2019, 8:09am
GNWLive @GNWLive
Fate Therapeutics Announces the Opening of its cGMP Manufacturing Facility Dedicated to iPSC-derived Cell $FATE https://t.co/6PI9suRyJk
September 30th 2019, 8:09am
dhovekamp42 @dhovekamp42
RT @JRMKE_: $FATE Updated their clinical trials for NK-100 (expanding to San Diego, Columbus and Dallas) and FT500 (expanding enrollment fr…
September 29th 2019, 3:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.